Applications of genetically manipulated mice in pharmacogenetics and pharmacogenomics

被引:10
作者
Kimura, S [1 ]
Gonzalez, F [1 ]
机构
[1] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA
关键词
cytochrome P450; xenobiotic-metabolizing enzymes; gene knockout mouse; transgenic mouse; pharmacogenetics; pharmacogenomics;
D O I
10.1159/000028395
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Gene knockout mice have proven to be very useful in understanding the role of xenobiotic-metabolizing enzymes in chemical toxicity and carcinogenesis, The combination of gene knockout technology with transgenic mouse technology should provide more versatile and suitable animal models to study the risks of chemical exposures in humans in terms of toxicity and carcinogenesis, as well as development and design of new therapeutic drugs, Recent studies using genetically manipulated mice are summarized. Copyright (C) 2000 S. Karger AG. Basel.
引用
收藏
页码:147 / 153
页数:7
相关论文
共 36 条
[11]   PHARMACOGENETIC PHENOTYPING AND GENOTYPING - PRESENT STATUS AND FUTURE POTENTIAL [J].
GONZALEZ, FJ ;
IDLE, JR .
CLINICAL PHARMACOKINETICS, 1994, 26 (01) :59-70
[12]   EVOLUTION OF THE P450-GENE SUPERFAMILY - ANIMAL PLANT WARFARE, MOLECULAR DRIVE AND HUMAN GENETIC-DIFFERENCES IN DRUG OXIDATION [J].
GONZALEZ, FJ ;
NEBERT, DW .
TRENDS IN GENETICS, 1990, 6 (06) :182-186
[13]   Comparisons of catalytic selectivity of cytochrome P450 subfamily enzymes from different species [J].
Guengerich, FP .
CHEMICO-BIOLOGICAL INTERACTIONS, 1997, 106 (03) :161-182
[14]  
GUENGERICH FP, 1982, REV BIOCHEM TOXICOL, V4, P5
[15]  
GUENGERICH FP, 1995, TAKAMATSU S, V23, P78
[16]   Cytochrome P-450 3A4: Regulation and role in drug metabolism [J].
Guengrich, FP .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 :1-17
[17]  
Hengstler JG, 1998, RECENT RES CANCER, V154, P47
[18]   TISSUE-SPECIFIC EXPRESSION OF THE MOUSE DIOXIN-INDUCIBLE P1450 AND P3450 GENES - DIFFERENTIAL TRANSCRIPTIONAL ACTIVATION AND MESSENGER-RNA STABILITY IN LIVER AND EXTRAHEPATIC TISSUES [J].
KIMURA, S ;
GONZALEZ, FJ ;
NEBERT, DW .
MOLECULAR AND CELLULAR BIOLOGY, 1986, 6 (05) :1471-1477
[19]   CYP1A2 is not the primary enzyme responsible for 4-aminobiphenyl-induced hepatocarcinogenesis in mice [J].
Kimura, S ;
Kawabe, M ;
Ward, JM ;
Morishima, H ;
Kadlubar, FF ;
Hammons, GJ ;
Fernandez-Salguero, P ;
Gonzalez, FJ .
CARCINOGENESIS, 1999, 20 (09) :1825-1830
[20]  
LANG NP, 1994, CANCER EPIDEM BIOMAR, V3, P675